Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "1H25"


5 mentions found


Morgan Stanley accompanied the move by cutting its price target to $100 from $120. His $185 price target, up from $160, forecasts that shares of Take-Two could rally 23% from Wednesday's close. — Lisa Kailai Han 5:55 a.m.: Bernstein initiates Ford at an outperform rating Investors who don't own Ford are missing out, according to Bernstein. — Lisa Kailai Han 5:55 a.m.: JPMorgan upgrades Hasbro Don't expect Hasbro's momentum to slow in the near future, according to JPMorgan. It also raised its price target on shares to $74 from $61, implying upside of 22%.
Persons: Bernstein, Morgan Stanley downgrades NetEase, Morgan Stanley, Alex Poon, Poon, Lisa Kailai Han, Omar Dessouky, Dessouky, — Lisa Kailai Han, Sam Poser, Sean Dodge, Dodge, GoodRx, Ford, Daniel Roeska, Roeska didn't, Roeska, Christopher Horvers, Fred Imbert Organizations: CNBC, Ford, JPMorgan, Hasbro, NetEase, Bank of America, Rockstar Games, Rockstar, Supreme, Corp, Trading, EMEA, Timberland, RBC, RBC Capital Markets, pharma, Kroger Locations: China, Wednesday's, Americas
Bank of America reiterates Nvidia as buy Bank of America raised its price target on the stock to $1,320 per share from $1,100 following earnings. Deutsche Bank initiates Freshpet a buy Deutsche said it sees "multiple structural tailwinds" for shares of the pet food and health company. Deutsche Bank initiates BellRing Brands as buy Deutsche said it sees a long runway for growth for the food company. " Deutsche Bank initiates Legend Biotech as buy Deutsche said it's bullish on the biotech company's multiple myeloma drug Carvykti. Bank of America reiterates Super Micro Computer as buy Bank of America said Nvidia's earnings report on Wednesday bode well for companies like Super Micro.
Persons: Bernstein, Ford, Morgan Stanley downgrades NetEase, Morgan Stanley, Evercore, BRBR, Wedbush, Jefferies, GDRX, Oppenheimer, Armour, Kevin, Dell, Chubb, Stephens, FHN, Tesla, Argus, it's bullish, bode Organizations: " Bank of America, Nvidia, Bank of America, Deutsche Bank, Deutsche, BellRing Brands, JPMorgan, Hasbro, RBC, Norfolk Southern, NSC, GE Vernova, GE, UBS, Eastman Chemical, Eastman, SAP, underperform Bank of America, Berkshire Hathaway's, of America, Rockstar Games, NextEra Energy Partners, Argus, Wynn, Biotech, Computer Locations: U.S, China, Berkshire, Macau, Las Vegas, 2H24
A major U.S. bank and a legacy tech name were the focus of some of Tuesday's biggest analyst calls. The firm upgraded the apparel stock to overweight from neutral, and raised its price target to $31 per share from $26. The firm resumed coverage of the legacy tech company with an overweight rating and a $58 per share price target. He reiterated his $64 price target on the stock, implying upside of 10.7%. Additionally, he sees "greater risk to the achievement of our price target as the Fed rate cutting cycle begin."
Persons: Morgan Stanley, Matthew Boss, — Brian Evans, Goldman Sachs, Molson Coors Goldman Sachs, Molson, Molson Coors, Bonnie Herzog, Bud Light, Brian Evans, Goldman, Mark Delaney, Cisco, Morgan Stanley's, David Rochester, Fred Imbert Organizations: CNBC, Cisco Systems, JPMorgan, Eagle Outfitters JPMorgan, American Eagle Outfitters, Eagle Outfitters, Molson Coors, Molson, TAP, Tesla, Cisco, Wells Locations: U.S, Wells, Americas, EVs, Wells Fargo, 2H24, Rochester
The EV maker got a price target cut from Citi, citing concern round the company's upcoming delivery numbers. Jonas has an overweight rating and $320 price target on shares, which suggests more than 85% upside potential for the shares. — Hakyung Kim 5:31 a.m.: Citi cuts Tesla price target Citi thinks there's not much upside potential for Tesla ahead of the release of its Q1 production and delivery numbers. As a result, the firm lowered its price target on shares to $196 from $224. He did, however, raise his price target to $62 from $56, with the new forecast calling for 9% upside.
Persons: Tesla, Wells Fargo, Morgan Stanley Morgan Stanley's Adam Jonas, Jonas, — Hakyung Kim, there's, Itay Michaeli, Michaeli, Hakyung Kim, David Konrad, Konrad, Fred Imbert Organizations: CNBC, Citi, KBW, EV Locations: Nevada, U.S, Tuesday's, Wells Fargo Wells Fargo, 1H25
Immunovant could emerge as a key player in the autoimmune space, according to JPMorgan. The bank initiated coverage of the biotech stock at an overweight rating, also setting a price target of $51. That implies that shares of Immunovant could rally more than 37% from their Friday closing price of $37.13. Immunovant stock has slid 9% so far this quarter. IMVT YTD mountain IMVT YTD chart As a key catalyst, the analyst underscored Immunovant's stats as one of the key players using anti-neonatal Fc receptor technology, or anti-FcRn technology, to treat autoimmune diseases.
Persons: Brian Cheng, Graves, Cheng, — CNBC's Michael Bloom Organizations: JPMorgan, IMVT, Telavant, Merck, Prometheus Locations: Immunovant, IMVT, Roche
Total: 5